NeuroMetrix, Inc. Announces WellMed Medical Management's Integration of NC-stat® DPNCheck™ Into Their Patient Evaluation Program

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com, a medical device company focused on the diagnosis and treatment of the neurological complications of diabetes, reported today that WellMed Medical Management, a San Antonio, Texas-based diversified healthcare company and healthcare provider, is integrating the NC-stat DPNCheck into their patient evaluation program. WellMed plans to have NC-stat DPNCheck in all their facilities, including more than 45 primary care clinics in Texas and Florida, and at most of the independent physician clinics in their service network. WellMed provides an innovative healthcare delivery system for Medicare-eligible patients. It is recognized as an industry leader in medical risk management, highly effective disease management and chronic care programs, and efficient healthcare delivery services.